BioCentrum opens GLP lab
Kraków – BioCentrum Sp. zo.o. is expanding contract research activities for the bio-pharmaceutical industry. In December, the Polish specialist for preclinical ADME, cell-based assays, protein characterisation, antibody, enzyme and heterologous protein manufacture, crystallographic analysis, and chemical synthesis opened a new R&D centre at Jagiellonian University campus. Around half a million euros of the investment money for the new unit – which includes an LC-MS, LIMS and equipment for chemical analysis – came from strategic investor Selvita, according to the company. BioCentrum has filed for a GLP certificate. “This will help us improve our market position in Poland and abroad,” said company founder Prof. Adam Dubin (CEO), who plans to hire new staff. The site will expand further in February, as Dubin expects an increase in demand for services after the firm’s trips to several biotech and pharma trade fairs in 2008. Shortly before its new R&D centre opened, BioCentrum published a white paper on pre-clinical outsourcing to Poland that placed Kraków at the forefront of future development. This is in line with expected growth of the clinical research market there. According to a market projection of Polish consultancy PMR, the clinical research market could expand from its current a169m to a212m by 2010.